Polygenic Risk Score (PRS)
A simple way to estimate your inherited risk for common conditions, using many small DNA signals together.
Clear explanation of what your percentile means
Strengths, limits, and what is clinically realistic
Turn risk into practical next steps
PRS in one easy definition
A
Polygenic Risk Score (PRS) is a number that estimates your
genetic tendency toward a condition by adding up the tiny effects of many genetic variants across your DNA.
Think of it like a risk tally, not a verdict. PRS does not mean you will or will not get a condition. It is one input alongside lifestyle, age, sex, labs, and family history. [1,2]
Simple analogy
PRS is like a weather forecast for health risk. It can signal higher chance or lower chance, but it is not the storm itself.
History of PRS and why it was developed
PRS exists because many common diseases are influenced by
thousands of small genetic effects, not one single gene. Early genome-wide work showed that combining many variants could improve risk estimation, and a key paper in 2007 described how genome-wide SNP data could be used to predict complex disease risk in otherwise healthy individuals. [3]
As genetic datasets and methods grew, PRS became more standardized, with best-practice guidance for how to compute scores, validate performance, and avoid common interpretation mistakes. [2]
Why PRS can be useful
PRS is valuable because it can reveal risk patterns years before symptoms, sometimes even when routine risk factors look normal. That can support earlier prevention and better screening conversations. [1]
Earlier prevention planning
Identify who may benefit from earlier lifestyle support or closer follow-up [1]
Smarter screening timing
PRS is being studied as an add-on to decide who may need earlier or more frequent screening [1]
Explaining family patterns
sometimes risk is the combined effect of many small pushes rather than one single-gene cause [1]
Research and population health
Research and population health: stratify cohorts into risk groups for studies and prevention programs [7]
Important note: PRS performance varies by disease and ancestry. Some research cautions that PRS often performs poorly for broad population screening when used alone, and that claims should match real-world performance. [8]
Who might find PRS useful
Individuals
- People with a family history of heart disease, diabetes, cancer, asthma, or autoimmune disease who want clearer inherited risk context [1]
- People who want prevention-first support guided by risk, not averages [1]
Clinicians
Primary care, cardiology, endocrinology, preventive medicine, oncology risk clinics. PRS is being explored as an incremental signal alongside standard tools, not a replacement. [1]
Researchers, biobanks, digital health teams
Teams building predictive models that combine PRS plus clinical and lifestyle data [5]
"PRS becomes meaningful when it changes what you do next, in practical ways"
How PRS matters in day-to-day life:
- Check-ups that match risk: earlier attention to blood pressure, lipids, glucose, weight trend, sleep and stress depending on the condition [1]
- Lifestyle targets with more motivation: high-risk signals can strengthen commitment to habits that reduce overall risk [1]
- More personalized prevention conversations: shift from average guidelines to a plan that fits your biology and context [1]
PRS should not replace medical advice and should not be used to self-start medications. It is best used as a structured conversation tool with a professional. [1, 6]
What conditions can PRS estimate risk for
PRS is mainly used for common, complex diseases where many genes contribute small effects.
Cardiovascular
Coronary heart disease, atrial fibrillation, lipid traits [2,4,5]
Metabolic
Type 2 diabetes, obesity-related traits [2,5]
Cancer risk
Breast, prostate, colorectal and others depending on the score [2,5
Immune and inflammatory
Asthma and inflammatory conditions [2,5]
Kidney and chronic panels
Chronic disease panels under evaluation in health systems [5]
Current Trends in Polygenic Risk Score Research
The landscape of polygenic risk score (PRS) research is evolving rapidly, with several key themes emerging :
From a score to a workflow
health systems and networks are developing pipelines for selecting conditions, validating performance, and returning results responsibly [5].
Multi-ancestry and fairness
improving accuracy and calibration across diverse populations is a major priority [5].
Standardised reporting
of PRS studies now adhere to stronger reporting standards, enhancing transparency and reproducibility in research findings[6].
Healthy skepticism
some analyses find that PRS may underperform in individual risk prediction, particularly when expectations are not aligned with evidence [8].
How a PRS is calculated
At a high level:
- Large genetic studies identify variants linked to higher or lower risk
- Each variant gets a weight (effect size)
- Your PRS is computed as a weighted sum across many variants
- The result is often reported as a percentile (for example, top 5% vs average)
- Good practice includes ancestry-aware calibration and clear limitations [2,6]
Public resources like the PGS Catalog curate published scores and metadata needed to evaluate and apply them. [7]
How HealthCode.Gene can help
At HealthCode.Gene, we do not just generate numbers. We translate them into decisions.
PRS interpretation
Best for: you already have PRS results from a lab, biobank, or report.
You get:
- Plain-language explanation of your percentile
- What PRS can and cannot tell you
- Practical prevention and screening discussion points to take to your clinician
PRS model run
Best for: you have raw genotype data (DTC or research) and want PRS computed responsibly.
Typical workflow:
- Data QC and format checks
- Use curated published scores and reproducible pipelines
- Ancestry-aware normalization and transparent limitations
- A report with “what next” questions for your clinician [2,6]
Clinics, startups, researchers
We can support:
- PRS pipeline setup (reproducible, documented)
- Multi-disease PRS panel selection strategy
- Validation support and reporting templates
- Patient and clinician education content (decks, visuals, one-pagers) [5,6]
Quick FAQ
Is PRS a diagnosis?
Can lifestyle override genetic risk?
Does PRS work equally well for everyone?
What is a good use of PRS today?
References
- [1] Kullo IJ. Clinical use of polygenic risk scores: current status, barriers and future directions. Nature Reviews Genetics (2025). View
- [2] Choi SW, Mak TSH, O’Reilly PF. Tutorial: a guide to performing polygenic risk score analyses. Nature Protocols (2020). View
- [3] Wray NR, Goddard ME, Visscher PM. Prediction of individual genetic risk to disease from genome-wide association studies. Genome Research (2007). View
- [4] Khera AV et al. Genome-wide polygenic scores for common diseases identify individuals with risk equivalent to monogenic mutations. Nature Genetics (2018). View
- [5] Lennon NJ et al. Selection, optimization and validation of ten chronic disease polygenic risk scores for clinical implementation in diverse US populations. Nature Medicine (2024). View
- [6] Wand H et al. Improving reporting standards for polygenic scores in risk prediction studies. Nature (2021). View
- [7] PGS Catalog. Polygenic Score (PGS) Catalog resources and updates (accessed 2025). View
- [8] Hingorani AD et al. Performance of polygenic risk scores in screening, prediction and risk stratification: secondary analysis of data in the Polygenic Score Catalog. BMJ Medicine (2023). View
- [9] Wray NR et al. (2007) as above. Early framing of genome-wide prediction concept. View
- [10] Choi SW et al. (2020) as above. Practical methods and interpretation guidance. View